Sun Pharma Advanced Research Company Limited
35
2
3
25
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
17.1%
6 terminated/withdrawn out of 35 trials
80.6%
-5.9% vs industry average
20%
7 trials in Phase 3/4
44%
11 of 25 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (35)
Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to Previous Treatments
Role: lead
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
Role: lead
PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706
Role: lead
Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies
Role: lead
A Study in Patients With Advanced Breast Cancer
Role: lead
Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects
Role: lead
K0706 for Patients Diagnosed With Dementia With Lewy Bodies
Role: collaborator
Evaluation of Safety and Efficacy of PDP-716
Role: lead
Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer
Role: lead
Evaluation of Efficacy and Safety of SDN-037
Role: lead
Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension
Role: lead
Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension
Role: lead
A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507
Role: lead
To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer
Role: lead
Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease
Role: lead
To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers
Role: lead
Efficacy and Safety of SPARC0921 in Subjects With Spasticity
Role: lead
Bioavailability Study of K0706 in Healthy Subjects
Role: lead
Bioavailability Study of SPARC001(Study 1) in Healthy Adult Volunteers
Role: lead
Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain
Role: lead